Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 2;10(11):e0005093.
doi: 10.1371/journal.pntd.0005093. eCollection 2016 Nov.

Containing Ebola at the Source with Ring Vaccination

Affiliations

Containing Ebola at the Source with Ring Vaccination

Stefano Merler et al. PLoS Negl Trop Dis. .

Abstract

Interim results from the Guinea Ebola ring vaccination trial suggest high efficacy of the rVSV-ZEBOV vaccine. These findings open the door to the use of ring vaccination strategies in which the contacts and contacts of contacts of each index case are promptly vaccinated to contain future Ebola virus disease outbreaks. To provide a numerical estimate of the effectiveness of ring vaccination strategies we introduce a spatially explicit agent-based model to simulate Ebola outbreaks in the Pujehun district, Sierra Leone, structurally similar to previous modelling approaches. We find that ring vaccination can successfully contain an outbreak for values of the effective reproduction number up to 1.6. Through an extensive sensitivity analysis of parameters characterising the readiness and capacity of the health care system, we identify interventions that, alongside ring vaccination, could increase the likelihood of containment. In particular, shortening the time from symptoms onset to hospitalisation to 2-3 days on average through improved contact tracing procedures, adding a 2km spatial component to the vaccination ring, and decreasing human mobility by quarantining affected areas might contribute increase our ability to contain outbreaks with effective reproduction number up to 2.6. These results have implications for future control of Ebola and other emerging infectious disease threats.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Ring vaccination with baseline parameters.
A Probability (with 95%CI; exact binomial test) of an uncontained outbreak (more than 300 cases) after introducing one infected case into a fully susceptible population for a range of Re values. The dashed line represents the theoretical value 1 − 1/Re under a homogeneous mixing assumption. B Estimated epidemic prevention potential and 95%CI for a range of Re values. The shaded grey area denotes the most plausible Re values for the 2014–15 West African epidemic. C Mean number of vaccine doses and 95%CIs for containing an outbreak for a range of Re values. D As C but for the number of rings defined. Each estimate is based on 1,000 simulated outbreaks.
Fig 2
Fig 2. Sensitivity analysis.
A Estimated epidemic prevention potential (points) and 95%CI (vertical lines) as a function of Re and by varying the vaccine coverage. Baseline coverage: 65% [4]. The shaded grey area represents the range of most plausible values of Re for the 2014–15 epidemic in West Africa. B As in A but by varying the eligible population. Symbols: C indicates contacts of index cases; CC indicates contacts of contacts; S indicates geographical rings (ring radius: 2 km). Baseline value: C&CC [4]. C As in A but by varying the parameter regulating human mobility. Spatial transmission is proportional to a power law kernel 1/(1 + db) where d is the geographical distance and b regulates the decrease of transmission with distance. Baseline value: b = 2.25, resulting in an average distance of 7.7 km [23]. Other scenarios assume different values of b, corresponding to an average distance ranging from 1.5 to 25 km. In these scenarios, probabilities of outbreaks in the absence of interventions were recomputed for each value of the parameter b. D As in A but by varying the time from symptoms onset to hospitalisation. Baseline value: 4 days [9]. Each estimate is based on 1,000 simulated outbreaks.
Fig 3
Fig 3
A Estimated epidemic prevention potential and 95%CI for a range of Re values using three ring-defining strategies: contacts and contacts of contacts (C&CC) of index cases; C&CC with a spatial ring of radius 2km around index cases (C&CC+S); C&CC+S (2km) plus “improved health systems”, which includes reducing time to isolation of cases (2–3 days from onset to hospitalisation), increasing ring vaccination coverage to 90% of eligible individuals, and reducing public access to infected areas. The shaded grey area denotes the most plausible Re values for the 2014–15 epidemic in West Africa. B As A but considering mass vaccination (coverage 25% and 50%) and a spatial ring (S) of 20km around index cases. Each estimate is based on 1,000 simulated outbreaks.

References

    1. Dixon MG, Schafer IJ, et al. Ebola viral disease outbreak—West Africa, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(25):548–51. - PMC - PubMed
    1. World Health Organization. Ebola situation report—30 March 2016; 2016. http://apps.who.int/ebola/current-situation/ ebola-situation-report-30-march-2016.
    1. Ebola ça Suffit Ring Vaccination Trial Consortium and others. The ring vaccination trial: a novel cluster randomized controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ. 2015;351:h3740 10.1136/bmj.h3740 - DOI - PMC - PubMed
    1. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. The Lancet. 2015;386(9996):857–866. - PubMed
    1. Geddes AM. The history of smallpox. Clinics in dermatology. 2006;24(3):152–157. 10.1016/j.clindermatol.2005.11.009 - DOI - PubMed

MeSH terms